HALO Insider Trading

Insider Ownership Percentage: 2.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $6,547,200.00

Halozyme Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Halozyme Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Halozyme Therapeutics Share Price & Price History

Current Price: $42.01
Price Change: Price Increase of +0.8 (1.94%)
As of 05/8/2024 01:00 AM ET

This chart shows the closing price history over time for HALO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Halozyme Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/17/2024Michael J. LaBarreSVPSell10,000$38.49$384,900.00168,176View SEC Filing Icon  
3/12/2024Michael J. LaBarreSVPSell10,000$41.64$416,400.00156,558View SEC Filing Icon  
2/28/2024Michael J. LaBarreSVPSell10,000$39.55$395,500.00156,558View SEC Filing Icon  
12/12/2023Michael J. LaBarreSVPSell10,000$39.63$396,300.00151,911View SEC Filing Icon  
10/17/2023Michael J. LaBarreSVPSell10,000$36.52$365,200.00151,911View SEC Filing Icon  
9/19/2023Michael J. LaBarreSVPSell10,000$39.10$391,000.00151,911View SEC Filing Icon  
8/31/2023Helen TorleyCEOSell10,000$42.82$428,200.00623,666View SEC Filing Icon  
8/29/2023Helen TorleyCEOSell10,000$42.40$424,000.00623,666View SEC Filing Icon  
8/22/2023Michael J. LaBarreSVPSell10,000$42.41$424,100.00151,911View SEC Filing Icon  
8/22/2023Michael J. LaBarreSVPSell10,000$42.41$424,100.00151,911View SEC Filing Icon  
8/17/2023Helen TorleyCEOSell10,000$43.18$431,800.00623,666View SEC Filing Icon  
8/14/2023James M. DalyDirectorSell10,000$43.74$437,400.0020,503View SEC Filing Icon  
8/11/2023James M. DalyDirectorSell10,000$43.71$437,100.0030,503View SEC Filing Icon  
7/26/2023Helen TorleyCEOSell10,000$42.69$426,900.00623,666View SEC Filing Icon  
7/18/2023Michael J. LaBarreSVPSell10,000$40.43$404,300.00141,911View SEC Filing Icon  
6/21/2023Michael J. LaBarreSVPSell10,000$36.00$360,000.00141,911View SEC Filing Icon  
4/18/2023Michael J. LaBarreSVPSell10,000$36.00$360,000.00141,911View SEC Filing Icon  
3/9/2023Helen TorleyCEOSell10,000$42.73$427,300.00623,666View SEC Filing Icon  
3/7/2023Helen TorleyCEOSell10,000$45.47$454,700.00623,666View SEC Filing Icon  
3/1/2023Jeffrey William HendersonDirectorSell10,000$47.71$477,100.0039,045View SEC Filing Icon  
2/27/2023Michael J. LaBarreSVPSell10,000$49.55$495,500.00138,927View SEC Filing Icon  
2/16/2023Helen TorleyCEOSell11,061$49.26$544,864.86633,666View SEC Filing Icon  
2/16/2023Nicole LabrosseCFOSell2,525$49.26$124,381.509,066View SEC Filing Icon  
2/15/2023Michael J. LaBarreSVPSell10,000$48.39$483,900.00143,477View SEC Filing Icon  
2/8/2023Helen TorleyCEOSell10,000$51.36$513,600.00587,177View SEC Filing Icon  
1/19/2023Helen TorleyCEOSell10,000$52.41$524,100.00587,177View SEC Filing Icon  
1/17/2023Michael J. LaBarreSVPSell10,000$50.46$504,600.00143,137View SEC Filing Icon  
12/15/2022Helen TorleyCEOSell10,000$57.37$573,700.00587,177View SEC Filing Icon  
12/13/2022Michael J. LaBarreSVPSell10,000$58.67$586,700.00153,137View SEC Filing Icon  
12/5/2022Matthew L. PosardDirectorSell10,000$55.74$557,400.00115,189View SEC Filing Icon  
12/2/2022Matthew L. PosardDirectorSell10,000$58.80$588,000.00125,189View SEC Filing Icon  
11/17/2022Helen TorleyCEOSell10,000$52.15$521,500.00587,177View SEC Filing Icon  
11/15/2022Michael J. LaBarreSVPSell10,000$54.13$541,300.00163,137View SEC Filing Icon  
11/15/2022Nicole LabrosseCFOSell5,000$53.81$269,050.004,045View SEC Filing Icon  
11/8/2021Helen TorleyCEOSell50,000$39.82$1,991,000.00View SEC Filing Icon  
11/5/2021Connie MatsuiDirectorSell32,000$40.38$1,292,160.00View SEC Filing Icon  
10/4/2021Helen TorleyCEOSell50,000$40.09$2,004,500.00View SEC Filing Icon  
10/1/2021Michael J. LaBarreSVPSell29,450$39.93$1,175,938.50View SEC Filing Icon  
9/7/2021Helen TorleyCEOSell50,000$42.38$2,119,000.00587,160View SEC Filing Icon  
8/25/2021Jean-Pierre BizzariDirectorSell35,000$41.01$1,435,350.00View SEC Filing Icon  
8/10/2021Helen TorleyCEOSell50,000$41.11$2,055,500.00View SEC Filing Icon  
7/6/2021Helen TorleyCEOSell50,000$45.97$2,298,500.00587,160View SEC Filing Icon  
7/1/2021Michael J. LaBarreSVPSell40,315$45.70$1,842,395.50View SEC Filing Icon  
6/7/2021Helen TorleyCEOSell50,000$39.66$1,983,000.00587,160View SEC Filing Icon  
5/11/2021Helen TorleyCEOSell50,000$43.02$2,151,000.00587,160View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Halozyme Therapeutics (NASDAQ:HALO)

97.79% of Halozyme Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HALO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Halozyme Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/9/2024TD Asset Management Inc2,541,266$103.38M0.1%+28.1%2.000%Search for SEC Filing on Google Icon
5/8/2024Advisors Preferred LLC24,847$1.03M0.2%N/A0.020%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC38,662$1.57M0.0%+4.9%0.030%Search for SEC Filing on Google Icon
5/8/2024US Bancorp DE13,912$0.57M0.0%+64.6%0.011%Search for SEC Filing on Google Icon
5/7/2024Tectonic Advisors LLC18,241$0.74M0.1%N/A0.014%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank260,900$10.61M0.0%+0.3%0.205%Search for SEC Filing on Google Icon
5/7/2024Steamboat Capital Partners LLC171,949$7M2.4%+1.7%0.135%Search for SEC Filing on Google Icon
5/7/2024ClariVest Asset Management LLC68,553$2.79M0.3%-0.4%0.054%Search for SEC Filing on Google Icon
5/7/2024Mesirow Institutional Investment Management Inc.364,047$14.81M1.3%-19.8%0.287%Search for SEC Filing on Google Icon
5/6/2024LSV Asset Management461,800$18.79M0.0%-0.1%0.363%Search for SEC Filing on Google Icon
5/6/2024Envestnet Portfolio Solutions Inc.9,451$0.38M0.0%-14.7%0.007%Search for SEC Filing on Google Icon
5/6/2024Duality Advisers LP26,094$1.06M0.1%-50.7%0.021%Search for SEC Filing on Google Icon
5/6/2024Gallacher Capital Management LLC9,244$0.38M0.2%-18.9%0.007%Search for SEC Filing on Google Icon
5/6/2024Texas Permanent School Fund Corp114,745$4.67M0.0%+0.6%0.090%Search for SEC Filing on Google Icon
5/3/2024Callan Capital LLC5,128$0.21M0.0%N/A0.004%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP11,217$0.46M0.0%+54.6%0.009%Search for SEC Filing on Google Icon
5/3/2024BI Asset Management Fondsmaeglerselskab A S14,577$0.59M0.0%-88.5%0.011%Search for SEC Filing on Google Icon
5/3/2024Central Pacific Bank Trust Division2,820$0.12M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/3/2024Whittier Trust Co.672$27K0.0%N/A0.001%Search for SEC Filing on Google Icon
5/2/2024Mutual of America Capital Management LLC140,327$5.71M0.1%-5.4%0.110%Search for SEC Filing on Google Icon
5/2/2024Fidelis Capital Partners LLC1,284$52K0.0%N/A0.001%Search for SEC Filing on Google Icon
5/1/2024Janney Montgomery Scott LLC16,454$0.67M0.0%+28.7%0.013%Search for SEC Filing on Google Icon
5/1/2024Oak Ridge Investments LLC71,923$2.93M0.3%-5.0%0.057%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.78,664$2.92M0.0%+2.9%0.062%Search for SEC Filing on Google Icon
5/1/2024Diversify Advisory Services LLC8,331$0.34M0.0%N/A0.007%Search for SEC Filing on Google Icon
4/30/2024Private Advisor Group LLC22,341$0.91M0.0%-4.7%0.018%Search for SEC Filing on Google Icon
4/30/2024Retirement Systems of Alabama165,881$6.75M0.0%+0.3%0.131%Search for SEC Filing on Google Icon
4/30/2024Norden Group LLC12,816$0.52M0.0%+46.9%0.010%Search for SEC Filing on Google Icon
4/30/2024Allspring Global Investments Holdings LLC696,127$28.32M0.0%-4.4%0.548%Search for SEC Filing on Google Icon
4/30/2024Commonwealth Equity Services LLC15,172$0.62M0.0%-9.5%0.012%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.570,757$23.22M0.0%+1.8%0.449%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.24,348$0.99M0.1%-55.0%0.019%Search for SEC Filing on Google Icon
4/26/2024Yousif Capital Management LLC61,072$2.48M0.0%-3.3%0.048%Search for SEC Filing on Google Icon
4/26/2024Mesirow Financial Investment Management Inc.8,500$0.35M0.0%N/A0.007%Search for SEC Filing on Google Icon
4/26/2024Verdence Capital Advisors LLC13,040$0.53M0.0%-10.5%0.010%Search for SEC Filing on Google Icon
4/25/2024Lindbrook Capital LLC1,542$63K0.0%-19.8%0.001%Search for SEC Filing on Google Icon
4/25/2024New York State Teachers Retirement System113,820$4.63M0.0%+0.4%0.090%Search for SEC Filing on Google Icon
4/25/2024WCM Investment Management LLC306,339$12.46M0.0%-3.2%0.241%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.52,840$2.15M0.0%-57.8%0.042%Search for SEC Filing on Google Icon
4/23/2024Louisiana State Employees Retirement System38,000$1.55M0.0%+2.4%0.030%Search for SEC Filing on Google Icon
4/23/2024Amalgamated Bank69,163$2.81M0.0%-16.4%0.054%Search for SEC Filing on Google Icon
4/23/2024Nations Financial Group Inc. IA ADV9,439$0.38M0.0%+48.1%0.007%Search for SEC Filing on Google Icon
4/19/2024AMI Asset Management Corp137,390$5.59M0.3%-4.0%0.108%Search for SEC Filing on Google Icon
4/19/2024First Trust Direct Indexing L.P.5,159$0.21M0.0%-8.7%0.004%Search for SEC Filing on Google Icon
4/19/2024Norden Group LLC167,284$6.81M0.1%+1,817.3%0.132%Search for SEC Filing on Google Icon
4/18/2024State of Michigan Retirement System32,438$1.32M0.0%+2.2%0.026%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC696,127$28.32M0.0%-4.4%0.548%Search for SEC Filing on Google Icon
4/16/2024Hodges Capital Management Inc.317,045$12.90M0.8%+61.4%0.250%Search for SEC Filing on Google Icon
4/15/2024Brookstone Capital Management61,710$2.51M0.0%+2.3%0.049%Search for SEC Filing on Google Icon
4/12/2024FCF Advisors LLC21,164$0.86M0.2%+1.9%0.017%Search for SEC Filing on Google Icon
4/11/2024Congress Asset Management Co. MA407,867$16.59M0.1%+16.2%0.321%Search for SEC Filing on Google Icon
4/10/2024Park Avenue Securities LLC8,294$0.34M0.0%+17.3%0.007%Search for SEC Filing on Google Icon
4/9/2024Rise Advisors LLC611$25K0.0%N/A0.000%Search for SEC Filing on Google Icon
4/5/2024First Hawaiian Bank5,041$0.21M0.0%-63.6%0.004%Search for SEC Filing on Google Icon
4/5/2024Juncture Wealth Strategies LLC7,459$0.30M0.1%N/A0.006%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC121,000$4.92M0.0%+17.2%0.095%Search for SEC Filing on Google Icon
4/5/2024CWM LLC800$33K0.0%-28.1%0.001%Search for SEC Filing on Google Icon
3/29/2024Kapitalo Investimentos Ltda3,593$0.13M0.0%-61.0%0.003%Search for SEC Filing on Google Icon
3/22/2024PNC Financial Services Group Inc.11,364$0.42M0.0%-4.2%0.009%Search for SEC Filing on Google Icon
3/21/2024Healthcare of Ontario Pension Plan Trust Fund105,000$3.88M0.0%N/A0.083%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.13,259,514$490.07M0.0%+1.2%10.436%Search for SEC Filing on Google Icon
3/5/2024Fisher Asset Management LLC276,902$10.23M0.0%+0.6%0.218%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP180,856$6.68M0.0%+16.1%0.143%Search for SEC Filing on Google Icon
3/4/2024Congress Asset Management Co. MA351,076$12.98M0.1%+15.6%0.277%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.1,541,610$56.98M0.0%-11.0%1.216%Search for SEC Filing on Google Icon
2/28/2024American International Group Inc.241,898$8.94M0.0%-3.1%0.191%Search for SEC Filing on Google Icon
2/26/2024Virtu Financial LLC16,421$0.61M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/26/2024Teachers Retirement System of The State of Kentucky44,021$1.63M0.0%-4.6%0.035%Search for SEC Filing on Google Icon
2/26/2024Neo Ivy Capital Management5,602$0.21M0.5%N/A0.004%Search for SEC Filing on Google Icon
2/20/2024Aurora Investment Counsel37,156$1.37M0.8%+5.4%0.028%Search for SEC Filing on Google Icon
2/15/2024Penn Capital Management Company LLC279,540$10.37M1.0%-13.9%0.212%Search for SEC Filing on Google Icon
2/14/2024First Light Asset Management LLC134,050$4.95M0.4%-57.2%0.101%Search for SEC Filing on Google Icon
2/14/2024Future Fund LLC7,166$0.27M0.7%-16.3%0.005%Search for SEC Filing on Google Icon
2/14/2024Scout Investments Inc.261,483$9.66M0.2%-1.5%0.198%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.6,030$0.22M0.1%-95.9%0.005%Search for SEC Filing on Google Icon
2/14/2024Prudential PLC33,773$1.25M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/13/2024Epoch Investment Partners Inc.1,163,033$42.99M0.2%+250.5%0.880%Search for SEC Filing on Google Icon
2/13/2024American International Group Inc.241,898$8.94M0.1%-3.1%0.183%Search for SEC Filing on Google Icon
2/13/2024Stephens Investment Management Group LLC1,518,455$56.12M0.8%+4.4%1.149%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC224,724$8.31M0.0%-2.8%0.170%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC17,369$0.64M0.1%+12.3%0.013%Search for SEC Filing on Google Icon
2/12/2024Eagle Asset Management Inc.232,113$8.58M0.0%-59.6%0.176%Search for SEC Filing on Google Icon
2/12/2024Evoke Wealth LLC36,657$1.36M0.0%N/A0.028%Search for SEC Filing on Google Icon
2/12/2024TD Asset Management Inc1,983,916$73.33M0.1%+517.0%1.502%Search for SEC Filing on Google Icon
2/12/2024United Services Automobile Association10,057$0.37M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/12/2024Bernzott Capital Advisors124,979$4.62M1.8%-27.3%0.095%Search for SEC Filing on Google Icon
2/12/2024Artisan Partners Limited Partnership6,689,058$247.23M0.4%-13.3%5.064%Search for SEC Filing on Google Icon
2/12/2024Hsbc Holdings PLC100,101$3.70M0.0%+27.7%0.076%Search for SEC Filing on Google Icon
2/9/2024Nations Financial Group Inc. IA ADV6,372$0.24M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/9/2024Congress Wealth Management LLC DE 52,511$1.94M0.0%+8.2%0.040%Search for SEC Filing on Google Icon
2/9/2024Hoylecohen LLC8,775$0.32M0.0%+8.3%0.007%Search for SEC Filing on Google Icon
2/9/2024Orion Portfolio Solutions LLC29,725$1.06M0.0%-15.9%0.023%Search for SEC Filing on Google Icon
2/9/2024Commerce Bank14,660$0.54M0.0%-3.2%0.011%Search for SEC Filing on Google Icon
2/9/2024Ontario Teachers Pension Plan Board34,346$1.27M0.0%+137.5%0.026%Search for SEC Filing on Google Icon
2/9/2024Affinity Investment Advisors LLC8,886$0.33M0.2%-43.4%0.007%Search for SEC Filing on Google Icon
2/9/2024Aigen Investment Management LP8,942$0.33M0.1%+35.9%0.007%Search for SEC Filing on Google Icon
2/9/2024Assetmark Inc.105,192$3.89M0.0%+71.1%0.080%Search for SEC Filing on Google Icon
2/9/2024GW&K Investment Management LLC2,226,538$82.29M0.8%-5.0%1.685%Search for SEC Filing on Google Icon
2/9/2024Quest Partners LLC11,789$0.44M0.1%N/A0.009%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP119,584$4.42M0.1%+4.3%0.091%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Halozyme Therapeutics logo
Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
Read More on Halozyme Therapeutics

Today's Range

Now: $42.01
Low: $41.43
High: $44.79

50 Day Range

MA: $40.09
Low: $37.81
High: $42.01

52 Week Range

Now: $42.01
Low: $29.85
High: $45.00

Volume

2,120,534 shs

Average Volume

1,217,735 shs

Market Capitalization

$5.34 billion

P/E Ratio

19.91

Dividend Yield

N/A

Beta

1.26

Who are the company insiders with the largest holdings of Halozyme Therapeutics?

Halozyme Therapeutics' top insider shareholders include:
  1. Helen Torley (CEO)
  2. Michael J Labarre (SVP)
  3. Matthew L Posard (Director)
  4. Jeffrey William Henderson (Director)
  5. James M Daly (Director)
  6. Nicole Labrosse (CFO)
Learn More about top insider investors at Halozyme Therapeutics.

Who are the major institutional investors of Halozyme Therapeutics?

Halozyme Therapeutics' top institutional investors include:
  1. TD Asset Management Inc — 2.00%
  2. Allspring Global Investments Holdings LLC — 0.55%
  3. Allspring Global Investments Holdings LLC — 0.55%
  4. Principal Financial Group Inc. — 0.45%
  5. LSV Asset Management — 0.36%
  6. Congress Asset Management Co. MA — 0.32%
Learn More about top institutional investors of Halozyme Therapeutics stock.

Which major investors are selling Halozyme Therapeutics stock?

Within the last quarter, HALO stock was sold by these institutional investors:
  1. BI Asset Management Fondsmaeglerselskab A S
  2. Mesirow Institutional Investment Management Inc.
  3. Assenagon Asset Management S.A.
  4. Allspring Global Investments Holdings LLC
  5. Allspring Global Investments Holdings LLC
  6. China Universal Asset Management Co. Ltd.
  7. Duality Advisers LP
  8. Amalgamated Bank
In the last year, company insiders that have sold Halozyme Therapeutics company stock include:
  1. Helen Torley (CEO)
  2. Michael J Labarre (SVP)
  3. Matthew L Posard (Director)
Learn More investors selling Halozyme Therapeutics stock.

Which major investors are buying Halozyme Therapeutics stock?

Within the last quarter, HALO stock was acquired by institutional investors including:
  1. TD Asset Management Inc
  2. Norden Group LLC
  3. Hodges Capital Management Inc.
  4. Congress Asset Management Co. MA
  5. Advisors Preferred LLC
  6. Tectonic Advisors LLC
  7. Los Angeles Capital Management LLC
  8. Oak Hill Wealth Advisors LLC